Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 5, 2015, Pages 1065-1076

  Hsu, Yu Lin ^a   Wang, Mei Yi ^a   Ho, Ling Jun ^b   Huang, Chuan Yueh ^b   Lai, Jenn Haung ^a,c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cell migration; Dendritic cells; Dengue virus; Galectin 9; Immune response; Mitogen activated protein kinase

Indexed keywords

DENGUE VIRUS;

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; GALECTIN; IMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; LGALS9 PROTEIN, HUMAN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CYTOLOGY; DENDRITIC CELL; DENGUE VIRUS; ENZYME ACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; VIROLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; DENDRITIC CELLS; DENGUE VIRUS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GALECTINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMIDAZOLES; INTERLEUKIN-12 SUBUNIT P40; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UP-REGULATION;

EID: 84928432705     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12500     Document Type: Article

References (47)

1. Hirabayashi J, Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993; 3: 297-304.
2. Sato S, Ouellet M, St-Pierre C, et al. Glycans, galectins, and HIV-1 infection. Ann N Y Acad Sci. 2012; 1253: 133-48.
3. Sundblad V, Croci DO, Rabinovich GA. Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues. Histol Histopath. 2011; 26: 247-65.
4. Imbeault M, Lodge R, Ouellet M, et al. Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population. Virology. 2009; 393: 160-7.
5. Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE. 2012; 7: e47648.
6. Kared H, Fabre T, Bedard N, et al. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog. 2013; 9: e1003422.
7. Seki M, Sakata KM, Oomizu S, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 2007; 56: 3968-76.
8. Rabinovich GA, Toscano MA, Jackson SS, et al. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol. 2007; 17: 513-20.
9. Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 2003; 4: 1102-10.
10. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005; 6: 1245-52.
11. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, et al. The costimulatory role of TIM molecules. Immunol Rev. 2009; 229: 259-70.
12. Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 2008; 127: 78-88.
13. Arikawa T, Saita N, Oomizu S, et al. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol. 2010; 40: 548-58.
14. Dardalhon V, Anderson AC, Karman J, et al. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol. 2010; 185: 1383-92.
15. Kojima K, Arikawa T, Saita N, et al. Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages. Am J Respir Crit Care Med. 2011; 184: 328-39.
16. Golden-Mason L, McMahan RH, Strong M, et al. Galectin-9 functionally impairs natural killer cells in humans and mice. J Virol. 2013; 87: 4835-45.
17. Moritoki M, Kadowaki T, Niki T, et al. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3. PLoS ONE. 2013; 8: e60807.
18. Matsuura A, Tsukada J, Mizobe T, et al. Intracellular galectin-9 activates inflammatory cytokines in monocytes. Genes Cells. 2009; 14: 511-21.
19. Jayaraman P, Sada-Ovalle I, Beladi S, et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med. 2010; 207: 2343-54.
20. Gieseke F, Kruchen A, Tzaribachev N, et al. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur J Immunol. 2013; 43: 2741-9.
21. Su EW, Bi S, Kane LP. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology. 2011; 21: 1258-65.
22. Ho LJ, Wang JJ, Shaio MF, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001; 166: 1499-506.
23. Warke RV, Xhaja K, Martin KJ, et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol. 2003; 77: 11822-32.
24. Chagan-Yasutan H, Ndhlovu LC, Lacuesta TL, et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J Clin Virol. 2013; 58: 635-40.
25. Ho LJ, Hung LF, Weng CY, et al. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol. 2005; 174: 8163-72.
26. Hsu YL, Shi SF, Wu WL, et al. Protective roles of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in dengue virus infection of human lung epithelial cells. PLoS ONE. 2013; 8: e79518.
27. Wu WL, Ho LJ, Chang DM, et al. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol. 2009; 39: 3413-22.
28. Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007; 318: 1141-3.
29. Tsai YT, Chang SY, Lee CN, et al. Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol. 2009; 11: 604-15.
30. Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood. 2009; 113: 1957-66.
31. Dai SY, Nakagawa R, Itoh A, et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol. 2005; 175: 2974-81.
32. Khader SA, Partida-Sanchez S, Bell G, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006; 203: 1805-15.
33. McSharry BP, Forbes SK, Cao JZ, et al. Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon. J Virol. 2014; 88: 10990-4.
34. Katoh S, Ikeda M, Shimizu H, et al. Increased levels of plasma galectin-9 in patients with influenza virus infection. Tohoku J Exp Med. 2014; 232: 263-7.
35. Jost S, Moreno-Nieves UY, Garcia-Beltran WF, et al. Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection. Retrovirology. 2013; 10:74.
36. Mengshol JA, Golden-Mason L, Arikawa T, et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE. 2010; 5: e9504.
37. Bi S, Hong PW, Lee B, et al. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci USA. 2011; 108: 10650-5.
38. + T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol. 2008; 181: 7660-9.
39. Slight SR, Lin Y, Messmer M, et al. Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor beta1. Cytokine. 2011; 55: 372-9.
40. Kohler T, Reizis B, Johnson RS, et al. Influence of hypoxia-inducible factor 1alpha on dendritic cell differentiation and migration. Eur J Immunol. 2012; 42: 1226-36.
41. Jung ID, Lee JS, Kim YJ, et al. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology. 2007; 121: 533-44.
42. Humrich JY, Thumann P, Greiner S, et al. Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells. Eur J Immunol. 2007; 37: 954-65.
43. Woodward AM, Mauris J, Argueso P. Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. J Virol. 2013; 87: 5841-7.
44. St-Pierre C, Manya H, Ouellet M, et al. Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J Virol. 2011; 85: 11742-51.
45. Nobumoto A, Nagahara K, Oomizu S, et al. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology. 2008; 18: 735-44.
46. Weisz OA, Rodriguez-Boulan E. Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci. 2009; 122: 4253-66.
47. Mo D, Costa SA, Ihrke G, et al. Sialylation of N-linked glycans mediates apical delivery of endolyn in MDCK cells via a galectin-9-dependent mechanism. Mol Biol Cell. 2012; 23: 3636-46.